These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 23625326)

  • 1. Triple therapy with darbepoetin alfa, idebenone, and riboflavin in Friedreich's ataxia: an open-label trial.
    Arpa J; Sanz-Gallego I; Rodríguez-de-Rivera FJ; Domínguez-Melcón FJ; Prefasi D; Oliva-Navarro J; Moreno-Yangüela M; Pascual-Pascual SI
    Cerebellum; 2013 Oct; 12(5):713-20. PubMed ID: 23625326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Triple therapy with deferiprone, idebenone and riboflavin in Friedreich's ataxia - open-label trial.
    Arpa J; Sanz-Gallego I; Rodríguez-de-Rivera FJ; Domínguez-Melcón FJ; Prefasi D; Oliva-Navarro J; Moreno-Yangüela M
    Acta Neurol Scand; 2014 Jan; 129(1):32-40. PubMed ID: 23668357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Friedreich's ataxia: idebenone treatment in early stage patients.
    Artuch R; Aracil A; Mas A; Colomé C; Rissech M; Monrós E; Pineda M
    Neuropediatrics; 2002 Aug; 33(4):190-3. PubMed ID: 12368988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Idebenone in Friedreich's ataxia.
    Tonon C; Lodi R
    Expert Opin Pharmacother; 2008 Sep; 9(13):2327-37. PubMed ID: 18710357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined therapy with idebenone and deferiprone in patients with Friedreich's ataxia.
    Velasco-Sánchez D; Aracil A; Montero R; Mas A; Jiménez L; O'Callaghan M; Tondo M; Capdevila A; Blanch J; Artuch R; Pineda M
    Cerebellum; 2011 Mar; 10(1):1-8. PubMed ID: 20865357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient-reported outcomes in Friedreich's ataxia after withdrawal from idebenone.
    Cook A; Boesch S; Heck S; Brunt E; Klockgether T; Schöls L; Schulz A; Giunti P
    Acta Neurol Scand; 2019 Jun; 139(6):533-539. PubMed ID: 30887496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma idebenone monitoring in Friedreich's ataxia patients during a long-term follow-up.
    Paredes-Fuentes AJ; Cesar S; Montero R; Latre C; Genovès J; Martorell L; Cuadras D; Colom H; Pineda M; Del Mar O'Callaghan M; Sarquella-Brugada G; Darling A; Artuch R
    Biomed Pharmacother; 2021 Nov; 143():112143. PubMed ID: 34507114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of neurological efficacy of idebenone in pediatric patients with Friedreich's ataxia: data from a 6-month controlled study followed by a 12-month open-label extension study.
    Meier T; Perlman SL; Rummey C; Coppard NJ; Lynch DR
    J Neurol; 2012 Feb; 259(2):284-91. PubMed ID: 21779958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Idebenone and reduced cardiac hypertrophy in Friedreich's ataxia.
    Hausse AO; Aggoun Y; Bonnet D; Sidi D; Munnich A; Rötig A; Rustin P
    Heart; 2002 Apr; 87(4):346-9. PubMed ID: 11907009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Idebenone in Friedreich ataxia cardiomyopathy-results from a 6-month phase III study (IONIA).
    Lagedrost SJ; Sutton MS; Cohen MS; Satou GM; Kaufman BD; Perlman SL; Rummey C; Meier T; Lynch DR
    Am Heart J; 2011 Mar; 161(3):639-645.e1. PubMed ID: 21392622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitochondrial dysfunction in Friedreich's ataxia: from pathogenesis to treatment perspectives.
    Lodi R; Rajagopalan B; Bradley JL; Taylor DJ; Crilley JG; Hart PE; Blamire AM; Manners D; Styles P; Schapira AH; Cooper JM
    Free Radic Res; 2002 Apr; 36(4):461-6. PubMed ID: 12069111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heart hypertrophy and function are improved by idebenone in Friedreich's ataxia.
    Rustin P; Rötig A; Munnich A; Sidi D
    Free Radic Res; 2002 Apr; 36(4):467-9. PubMed ID: 12069112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-dose idebenone treatment in Friedreich's ataxia with and without cardiac hypertrophy.
    Rinaldi C; Tucci T; Maione S; Giunta A; De Michele G; Filla A
    J Neurol; 2009 Sep; 256(9):1434-7. PubMed ID: 19363628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antioxidant treatment of patients with Friedreich ataxia: four-year follow-up.
    Hart PE; Lodi R; Rajagopalan B; Bradley JL; Crilley JG; Turner C; Blamire AM; Manners D; Styles P; Schapira AH; Cooper JM
    Arch Neurol; 2005 Apr; 62(4):621-6. PubMed ID: 15824263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurophysiological evaluation in children with Friedreich's ataxia.
    Sival DA; du Marchie Sarvaas GJ; Brouwer OF; Uges DR; Verschuuren-Bemelmans CC; Maurits NM; Brunt ER; van der Hoeven JH
    Early Hum Dev; 2009 Oct; 85(10):647-51. PubMed ID: 19775837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erythropoietin in Friedreich ataxia: no effect on frataxin in a randomized controlled trial.
    Mariotti C; Fancellu R; Caldarazzo S; Nanetti L; Di Bella D; Plumari M; Lauria G; Cappellini MD; Duca L; Solari A; Taroni F
    Mov Disord; 2012 Mar; 27(3):446-9. PubMed ID: 22411849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Co-enzyme Q10 and idebenone use in Friedreich's ataxia.
    Parkinson MH; Schulz JB; Giunti P
    J Neurochem; 2013 Aug; 126 Suppl 1():125-41. PubMed ID: 23859348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antioxidants and other pharmacological treatments for Friedreich ataxia.
    Kearney M; Orrell RW; Fahey M; Pandolfo M
    Cochrane Database Syst Rev; 2012 Apr; (4):CD007791. PubMed ID: 22513953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurological effects of high-dose idebenone in patients with Friedreich's ataxia: a randomised, placebo-controlled trial.
    Di Prospero NA; Baker A; Jeffries N; Fischbeck KH
    Lancet Neurol; 2007 Oct; 6(10):878-86. PubMed ID: 17826341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epoetin alfa and darbepoetin alfa: effects on ventricular hypertrophy in patients with chronic kidney disease.
    Chen HH; Tarng DC; Lee KF; Wu CY; Chen YC
    J Nephrol; 2008; 21(4):543-9. PubMed ID: 18651544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.